BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36402252)

  • 1. Down regulation of NDUFS1 is involved in the progression of parenteral-nutrition-associated liver disease by increasing Oxidative stress.
    Wan S; Maitiabula G; Wang P; Zhang Y; Gao X; Zhang L; Gao T; Wang X
    J Nutr Biochem; 2023 Feb; 112():109221. PubMed ID: 36402252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy May Protect Against Parenteral Nutrition-Associated Liver Disease by Suppressing Endoplasmic Reticulum Stress.
    Zhang T; Yan J; Wang N; Dai L; Wang Y; Cai W
    JPEN J Parenter Enteral Nutr; 2019 Jan; 43(1):96-106. PubMed ID: 29761871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease.
    Koelfat KVK; Schaap FG; Hodin CMJM; Visschers RGJ; Svavarsson BI; Lenicek M; Shiri-Sverdlov R; Lenaerts K; Olde Damink SWM
    Clin Nutr; 2017 Oct; 36(5):1403-1410. PubMed ID: 28029505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome characteristics of liver tissue from patients with parenteral nutrition-associated liver disease.
    Maitiabola G; Tian F; Sun H; Zhang L; Gao X; Xue B; Wang X
    Nutr Metab (Lond); 2020; 17():43. PubMed ID: 32518576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets.
    Guthrie G; Stoll B; Chacko S; Lauridsen C; Plat J; Burrin D
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G41-G52. PubMed ID: 31604032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of parenteral nutrition-associated liver disease in hospitalized adults: A prospective cohort study.
    Lakananurak N; Tienchai K
    Clin Nutr ESPEN; 2019 Dec; 34():81-86. PubMed ID: 31677717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early predictors of liver injury in patients on parenteral nutrition.
    Żalikowska-Gardocka M; Niewada M; Niewiński G; Iżycka M; Ratyńska A; Żurek M; Nawrot A; Przybyłkowski A
    Clin Nutr ESPEN; 2022 Oct; 51():319-322. PubMed ID: 36184223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease.
    El Kasmi KC; Anderson AL; Devereaux MW; Vue PM; Zhang W; Setchell KD; Karpen SJ; Sokol RJ
    Sci Transl Med; 2013 Oct; 5(206):206ra137. PubMed ID: 24107776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Metabolomic Analysis of Liver Tissues from Rat Models of Parenteral Nutrition-Associated Liver Disease.
    Wan S; Yang J; Mamtawla G; Zhang L; Gao X; Wang X
    Biomed Res Int; 2020; 2020():9156359. PubMed ID: 32280707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGR5 signaling mitigates parenteral nutrition-associated liver disease.
    Willis KA; Gomes CK; Rao P; Micic D; Moran ER; Stephenson E; Puchowicz M; Al Abdallah Q; Mims TS; Gosain A; Yin D; Talati AJ; Chang EB; Han JC; Pierre JF
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G322-G335. PubMed ID: 31905022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting GPX4-mediated Ferroptosis Alleviates Liver Steatosis in a Rat Model of Total Parenteral Nutrition.
    Cheng S; Wang Y; Zhao Y; Wang N; Yan J; Jiang L; Cai W
    J Pediatr Surg; 2024 May; 59(5):981-991. PubMed ID: 37968154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and treatment of parenteral nutrition-associated liver disease.
    Xu ZW; Li YS
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):586-93. PubMed ID: 23232629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs.
    Ng K; Stoll B; Chacko S; Saenz de Pipaon M; Lauridsen C; Gray M; Squires EJ; Marini J; Zamora IJ; Olutoye OO; Burrin DG
    JPEN J Parenter Enteral Nutr; 2016 Jul; 40(5):656-71. PubMed ID: 25596209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for parenteral nutrition–associated liver disease following surgical therapy for necrotizing enterocolitis: A Glaser Pediatric Research Network Study [corrected].
    Duro D; Mitchell PD; Kalish LA; Martin C; McCarthy M; Jaksic T; Dunn J; Brandt ML; Nobuhara KK; Sylvester KG; Moss RL; Duggan C
    J Pediatr Gastroenterol Nutr; 2011 May; 52(5):595-600. PubMed ID: 21464752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review and clinical update on parenteral nutrition-associated liver disease.
    Tillman EM
    Nutr Clin Pract; 2013 Feb; 28(1):30-9. PubMed ID: 23087263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease.
    Nandivada P; Cowan E; Carlson SJ; Chang M; Gura KM; Puder M
    Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):153-8. PubMed ID: 23602846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between congenital heart disease and parenteral nutrition-associated liver disease in neonates: A retrospective cohort study.
    Santharam Y; Nitkin CR; Rajgarhia A; Oschman A; Lee B; Fischer R; Feldman K
    JPEN J Parenter Enteral Nutr; 2023 May; 47(4):501-510. PubMed ID: 36772965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine mitigates parenteral nutrition-associated liver disease in a novel ambulatory piglet model.
    Song E; Nagarapu A; van Nispen J; Armstrong A; Manithody C; Murali V; Voigt M; Samaddar A; Hutchinson C; Jain S; Roenker J; Krebs J; Jain AK
    JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1384-1392. PubMed ID: 35072265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease.
    Christensen RD; Henry E; Wiedmeier SE; Burnett J; Lambert DK
    J Perinatol; 2007 May; 27(5):284-90. PubMed ID: 17344923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.